LabCompass

Matthew S. Stratton

Medicine · The Ohio State University

Mid career · publishing since 2007

Publications

80

Citations

1,414

Est. group size

~3

Recurring co-author estimate

Active years

20

Publishing since 2007

Research summary
AI-generated

Matthew S. Stratton's research centers on cardiovascular biology, particularly how the heart and blood vessels respond to stress, aging, and metabolic changes, including cardiac fibrosis, mitochondrial function, and vascular remodeling. Work spans molecular mechanisms (gene regulation, protein degradation pathways) to more applied studies involving diet, exercise, and medical device interventions. The lab collaborates on topics ranging from heart failure and vein graft treatments to aging-related dietary interventions like ketogenic diets and caloric restriction.

Cardiac fibrosis and remodelingMitochondrial and protein stress responsesVascular disease and interventionsAging, diet, and metabolic regulationGene expression regulation in cardiovascular disease

Publication output has remained fairly steady over the past decade, with a dip in 2023 followed by a notable increase in 2024, averaging just under 5 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.8/year recently
2017: 6 publications172018: 4 publications182019: 6 publications192020: 6 publications202021: 5 publications212022: 7 publications222023: 2 publications232024: 9 publications9242025: 3 publications252026: 3 publications26
Recent publications
Publishes in
  • Circulation Research×6
  • Journal of Molecular and Cellular Cardiology×6
  • Elsevier eBooks×5
  • bioRxiv (Cold Spring Harbor Laboratory)×5
  • Circulation×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile